Difference between revisions of "15 Best Documentaries On Pragmatic Free Trial Meta"

From
Jump to: navigation, search
m
m
 
(3 intermediate revisions by 3 users not shown)
Line 1: Line 1:
Pragmatic Free Trial Meta<br><br>Pragmatic Free Trail Meta is an open data platform that enables research into pragmatic trials. It shares clean trial data and ratings using PRECIS-2 allowing for multiple and diverse meta-epidemiological studies to evaluate the effect of treatment on trials that employ different levels of pragmatism and other design features.<br><br>Background<br><br>Pragmatic trials provide real-world evidence that can be used to make clinical decisions. The term "pragmatic" however, is used inconsistently and its definition and measurement need further clarification. Pragmatic trials must be designed to inform policy and clinical practice decisions, not to confirm an hypothesis that is based on a clinical or physiological basis. A pragmatic study should aim to be as similar to real-world clinical practice as possible, including in the recruitment of participants, 프라그마틱 정품확인방법 ([https://www.hesdeadjim.org/pragmaticplay5672 read this blog article from Muscleman]) setting up and design as well as the execution of the intervention, determination and analysis of outcomes and primary analysis. This is a significant distinction from explanatory trials (as described by Schwartz and Lellouch1), which are designed to provide more thorough confirmation of an idea.<br><br>Truely pragmatic trials should not blind participants or 라이브 카지노 ([http://muscleman.co.kr/main/bbs/board.php?bo_table=free&wr_id=229611 find out here now]) clinicians. This can result in a bias in the estimates of the effect of treatment. Practical trials should also aim to attract patients from a variety of health care settings, to ensure that their findings can be applied to the real world.<br><br>Additionally the focus of pragmatic trials should be on outcomes that are crucial to patients, like quality of life or functional recovery. This is especially important in trials that involve invasive procedures or those with potentially serious adverse events. The CRASH trial29, for instance focused on the functional outcome to compare a 2-page case-report with an electronic system to monitor the health of patients in hospitals suffering from chronic heart failure, and  [https://asdasolar.com/files/@pragmaticplay3915?page=about 프라그마틱] 정품 사이트 - [http://36.134.23.28:3000/pragmaticplay1496/pragmatickr4469/wiki/Five+Killer+Quora+Answers+To+Pragmatickr 36.134.23.28] - the catheter trial28 utilized urinary tract infections caused by catheters as its primary outcome.<br><br>In addition to these aspects, pragmatic trials should minimize the requirements for data collection and trial procedures to cut costs and time commitments. Finally pragmatic trials should try to make their findings as applicable to clinical practice as is possible by making sure that their primary analysis is the intention-to-treat approach (as described in CONSORT extensions for pragmatic trials).<br><br>Despite these criteria however,  [http://49.234.213.44/pragmaticplay0409 프라그마틱 정품] a large number of RCTs with features that defy the notion of pragmatism were incorrectly labeled pragmatic and published in journals of all kinds. This could lead to misleading claims of pragmaticity and the usage of the term must be standardized. The creation of a PRECIS-2 tool that can provide an objective, standardized evaluation of pragmatic aspects is a first step.<br><br>Methods<br><br>In a pragmatic research study the aim is to inform policy or clinical decisions by showing how an intervention can be integrated into routine treatment in real-world settings. Explanatory trials test hypotheses regarding the cause-effect relation within idealized conditions. Therefore, pragmatic trials might have lower internal validity than explanatory trials and may be more susceptible to bias in their design, conduct and analysis. Despite these limitations, pragmatic trials may contribute valuable information to decision-making in the context of healthcare.<br><br>The PRECIS-2 tool scores an RCT on 9 domains, ranging from 1 to 5 (very pragmatist). In this study, the domains of recruitment, organisation, flexibility in delivery, flexible adherence, and follow-up were awarded high scores. However, the principal outcome and the method for missing data scored below the pragmatic limit. This suggests that a trial can be designed with good pragmatic features, without harming the quality of the trial.<br><br>However, it is difficult to judge the degree of pragmatism a trial really is because pragmaticity is not a definite quality; certain aspects of a trial can be more pragmatic than others. Furthermore, logistical or protocol modifications during the course of an experiment can alter its score in pragmatism. Additionally 36% of 89 pragmatic trials identified by Koppenaal and colleagues were placebo-controlled or conducted before licensing and most were single-center. They aren't in line with the norm and are only referred to as pragmatic if their sponsors accept that such trials aren't blinded.<br><br>Furthermore, a common feature of pragmatic trials is that researchers try to make their results more valuable by studying subgroups of the sample. This can result in imbalanced analyses and less statistical power. This increases the possibility of omitting or misinterpreting differences in the primary outcomes. In the instance of the pragmatic trials included in this meta-analysis, this was a major issue since the secondary outcomes weren't adjusted for variations in the baseline covariates.<br><br>In addition, pragmatic studies can present challenges in the collection and interpretation safety data. This is due to the fact that adverse events are typically reported by participants themselves and are susceptible to delays in reporting, inaccuracies or coding errors. It is crucial to increase the accuracy and quality of the results in these trials.<br><br>Results<br><br>While the definition of pragmatism doesn't require that all clinical trials be 100% pragmatist There are advantages to including pragmatic components in trials. These include:<br><br>By including routine patients, the trial results are more easily translated into clinical practice. However, pragmatic trials can also have drawbacks. The right kind of heterogeneity, for example could allow a study to extend its findings to different patients or settings. However, the wrong type can reduce the sensitivity of an assay and, consequently, decrease the ability of a study to detect small treatment effects.<br><br>A variety of studies have attempted to classify pragmatic trials using a variety of definitions and scoring methods. Schwartz and Lellouch1 created a framework to distinguish between explanation-based trials that support the clinical or physiological hypothesis and pragmatic trials that help in the choice of appropriate therapies in real-world clinical practice. The framework was comprised of nine domains, each scoring on a scale of 1 to 5 with 1 being more informative and 5 suggesting more pragmatic. The domains were recruitment setting, setting, intervention delivery and follow-up, as well as flexible adherence and primary analysis.<br><br>The initial PRECIS tool3 had similar domains and a scale of 1 to 5. Koppenaal and colleagues10 developed an adaptation of this assessment, dubbed the Pragmascope that was simpler to use in systematic reviews. They discovered that pragmatic systematic reviews had higher average scores across all domains, with lower scores in the primary analysis domain.<br><br>This distinction in the primary analysis domains can be due to the way in which most pragmatic trials approach data. Certain explanatory trials however don't. The overall score was lower for pragmatic systematic reviews when the domains on organisation, flexible delivery and follow-up were merged.<br><br>It is important to remember that a pragmatic study does not mean that a trial is of poor quality. In fact, there are increasing numbers of clinical trials that employ the term 'pragmatic' either in their title or abstract (as defined by MEDLINE but which is not precise nor sensitive). These terms may signal that there is a greater appreciation of pragmatism in abstracts and titles, however it's not clear if this is reflected in the content.<br><br>Conclusions<br><br>In recent times, pragmatic trials are becoming more popular in research as the importance of real-world evidence is becoming increasingly acknowledged. They are clinical trials randomized that evaluate real-world alternatives to care instead of experimental treatments under development, they involve populations of patients which are more closely resembling the ones who are treated in routine medical care, they utilize comparators that are used in routine practice (e.g., existing drugs), and they depend on the self-reporting of participants about outcomes. This method could help overcome limitations of observational studies, such as the biases associated with reliance on volunteers and limited availability and coding variability in national registry systems.<br><br>Pragmatic trials offer other advantages, including the ability to leverage existing data sources and a higher probability of detecting meaningful differences than traditional trials. However, these tests could be prone to limitations that undermine their reliability and generalizability. For instance the participation rates in certain trials may be lower than anticipated due to the healthy-volunteer effect as well as incentives to pay or compete for participants from other research studies (e.g. industry trials). Many pragmatic trials are also restricted by the necessity to enroll participants on time. In addition some pragmatic trials lack controls to ensure that the observed differences are not due to biases in the conduct of trials.<br><br>The authors of the Pragmatic Free Trial Meta identified RCTs that were published between 2022 and 2022 that self-described themselves as pragmatic. They assessed pragmatism by using the PRECIS-2 tool that includes the eligibility criteria for domains, recruitment, flexibility in adherence to interventions and follow-up. They discovered that 14 of these trials scored pragmatic or highly practical (i.e., scoring 5 or higher) in one or more of these domains and that the majority of these were single-center.<br><br>Studies that have high pragmatism scores tend to have more lenient criteria for eligibility than conventional RCTs. They also have patients from a variety of hospitals. According to the authors, may make pragmatic trials more relevant and useful in the daily clinical. However they do not ensure that a study is free of bias. In addition, the pragmatism that is present in trials is not a definite characteristic and a pragmatic trial that does not have all the characteristics of a explanatory trial may yield valid and useful results.
+
Pragmatic Free Trial Meta<br><br>Pragmatic Free Trail Meta is an open data platform that allows research into pragmatic trials. It collects and distributes cleaned trial data, ratings, and evaluations using PRECIS-2. This allows for a variety of meta-epidemiological analyses that evaluate the effects of treatment across trials of various levels of pragmatism.<br><br>Background<br><br>Pragmatic trials are increasingly recognized as providing real-world evidence for clinical decision making. However, the usage of the term "pragmatic" is inconsistent and its definition and evaluation requires further clarification. The purpose of pragmatic trials is to inform policy and clinical practice decisions, not to confirm the validity of a clinical or physiological hypothesis. A pragmatic trial should try to be as close as is possible to real-world clinical practices, including recruitment of participants, setting, designing, delivery and implementation of interventions, determining and analysis outcomes, and primary analyses. This is a major difference between explanatory trials as defined by Schwartz &amp; Lellouch1 that are designed to confirm the hypothesis in a more thorough manner.<br><br>Truely pragmatic trials should not blind participants or the clinicians. This can result in a bias in the estimates of the effect of treatment. Pragmatic trials should also seek to attract patients from a wide range of health care settings, to ensure that the results can be compared to the real world.<br><br>Furthermore, trials that are pragmatic must be focused on outcomes that matter to patients, such as quality of life and functional recovery. This is particularly relevant in trials that involve surgical procedures that are invasive or have potential for dangerous adverse events. The CRASH trial29, for example was focused on functional outcomes to compare a 2-page case-report with an electronic system for monitoring of patients admitted to hospitals with chronic heart failure. In addition, the catheter trial28 used urinary tract infections caused by catheters as the primary outcome.<br><br>In addition to these characteristics pragmatic trials should reduce the trial procedures and [https://thebookmarklist.com/story18052630/20-resources-that-ll-make-you-more-effective-at-pragmatic-slots 프라그마틱 슬롯 사이트] [https://seolistlinks.com/story19388699/the-most-inspirational-sources-of-pragmatic-genuine 프라그마틱 정품확인]방법 - [https://isocialfans.com/story3453262/14-common-misconceptions-concerning-pragmatic-slots-free-trial isocialfans.com], data collection requirements in order to reduce costs. Additionally, pragmatic trials should aim to make their findings as applicable to current clinical practice as is possible. This can be accomplished by ensuring that their analysis is based on an intention-to treat approach (as described in CONSORT extensions).<br><br>Many RCTs that do not meet the criteria for pragmatism however, they have characteristics that are contrary to pragmatism have been published in journals of varying types and incorrectly labeled pragmatic. This could lead to false claims of pragmatism, and the use of the term should be standardized. The development of a PRECIS-2 tool that provides an objective and standardized evaluation of pragmatic aspects is a first step.<br><br>Methods<br><br>In a pragmatic study the goal is to inform policy or clinical decisions by showing how an intervention could be incorporated into real-world routine care. This is different from explanatory trials that test hypotheses regarding the causal-effect relationship in idealized conditions. Therefore, pragmatic trials might have lower internal validity than explanatory trials and might be more susceptible to bias in their design, conduct and analysis. Despite these limitations, pragmatic trials may contribute valuable information to decisions in the context of healthcare.<br><br>The PRECIS-2 tool evaluates an RCT on 9 domains, with scores ranging from 1 to 5 (very pragmatic). In this study, the recruit-ment organization, flexibility in delivery and follow-up domains scored high scores, however the primary outcome and the method of missing data were below the limit of practicality. This suggests that it is possible to design a trial that has good pragmatic features without damaging the quality of its results.<br><br>However, it is difficult to judge how practical a particular trial is since pragmaticity is not a definite attribute; some aspects of a trial can be more pragmatic than others. A trial's pragmatism can be affected by changes to the protocol or logistics during the trial. Koppenaal and colleagues found that 36% of 89 pragmatic studies were placebo-controlled, or conducted prior to the licensing. Most were also single-center. They aren't in line with the standard practice, and can only be called pragmatic if the sponsors agree that such trials aren't blinded.<br><br>Furthermore, a common feature of pragmatic trials is that researchers attempt to make their findings more meaningful by analysing subgroups of the trial. However, this can lead to unbalanced results and lower statistical power, which increases the risk of either not detecting or incorrectly detecting differences in the primary outcome. This was the case in the meta-analysis of pragmatic trials as secondary outcomes were not corrected for covariates that differed at the baseline.<br><br>In addition, pragmatic trials can also have challenges with respect to the gathering and interpretation of safety data. It is because adverse events tend to be self-reported and are susceptible to errors, delays or coding errors. Therefore, it is crucial to enhance the quality of outcomes ascertainment in these trials, in particular by using national registries instead of relying on participants to report adverse events in the trial's database.<br><br>Results<br><br>Although the definition of pragmatism does not require that all clinical trials are 100% pragmatist There are advantages when incorporating pragmatic components into trials. These include:<br><br>By incorporating routine patients, the results of the trial can be translated more quickly into clinical practice. However, pragmatic trials can also have drawbacks. The right kind of heterogeneity, [https://bookmarkuse.com/story17912084/the-top-companies-not-to-be-keep-an-eye-on-in-the-pragmatic-casino-industry 프라그마틱 무료스핀] 플레이 - [https://bookmarklogin.com/story18187229/pragmatic-free-trial-tools-to-simplify-your-daily-life click the up coming article] - like could help a study generalise its findings to many different patients or settings. However, the wrong type can reduce the sensitivity of an assay and thus reduce a trial's power to detect small treatment effects.<br><br>Numerous studies have attempted to categorize pragmatic trials, using various definitions and [https://topsocialplan.com/story3483208/the-top-pragmatic-slots-free-it-s-what-gurus-do-3-things 프라그마틱 슈가러쉬] scoring systems. Schwartz and Lellouch1 created a framework for distinguishing between research studies that prove a physiological or clinical hypothesis as well as pragmatic trials that aid in the selection of appropriate treatments in clinical practice. The framework was comprised of nine domains that were evaluated on a scale of 1-5 which indicated that 1 was more lucid while 5 was more pragmatic. The domains included recruitment, setting up, delivery of intervention, flex adherence and primary analysis.<br><br>The initial PRECIS tool3 included similar domains and an assessment scale ranging from 1 to 5. Koppenaal et al10 developed an adaptation of this assessment, known as the Pragmascope which was more user-friendly to use for systematic reviews. They discovered that pragmatic systematic reviews had higher average score in most domains, but lower scores in the primary analysis domain.<br><br>This difference in primary analysis domains could be explained by the way that most pragmatic trials analyse data. Certain explanatory trials however do not. The overall score for systematic reviews that were pragmatic was lower when the areas of organisation, flexible delivery and follow-up were merged.<br><br>It is important to remember that the term "pragmatic trial" does not necessarily mean a poor quality trial, and there is an increasing number of clinical trials (as defined by MEDLINE search, however this is not sensitive nor specific) which use the word 'pragmatic' in their abstracts or titles. These terms may signal a greater awareness of pragmatism within abstracts and titles, however it's unclear whether this is reflected in content.<br><br>Conclusions<br><br>As the value of real-world evidence grows popular, pragmatic trials have gained popularity in research. They are clinical trials randomized which compare real-world treatment options rather than experimental treatments under development. They have populations of patients that more closely mirror the ones who are treated in routine care, they use comparators which exist in routine practice (e.g., existing drugs) and depend on the self-reporting of participants about outcomes. This approach could help overcome the limitations of observational studies which include the biases that arise from relying on volunteers, and the limited accessibility and coding flexibility in national registry systems.<br><br>Other advantages of pragmatic trials are the possibility of using existing data sources, as well as a higher chance of detecting meaningful changes than traditional trials. However, these trials could be prone to limitations that compromise their reliability and generalizability. For instance, participation rates in some trials may be lower than anticipated due to the healthy-volunteer influence and financial incentives or competition for participants from other research studies (e.g., industry trials). A lot of pragmatic trials are restricted by the need to enroll participants in a timely manner. Practical trials aren't always equipped with controls to ensure that the observed differences aren't caused by biases during the trial.<br><br>The authors of the Pragmatic Free Trial Meta identified 48 RCTs that self-labeled themselves as pragmatic and that were published up to 2022. The PRECIS-2 tool was used to evaluate the pragmatism of these trials. It covers areas like eligibility criteria, recruitment flexibility and adherence to intervention and follow-up. They discovered that 14 of the trials scored pragmatic or highly practical (i.e. scores of 5 or higher) in one or more of these domains and that the majority were single-center.<br><br>Trials with high pragmatism scores are likely to have more lenient criteria for eligibility than conventional RCTs. They also have populations from many different hospitals. The authors suggest that these characteristics could make pragmatic trials more effective and relevant to daily practice, but they do not necessarily guarantee that a pragmatic trial is free of bias. Moreover, the pragmatism of the trial is not a fixed attribute; a pragmatic trial that does not have all the characteristics of an explanatory trial may yield valuable and reliable results.

Latest revision as of 05:38, 29 December 2024

Pragmatic Free Trial Meta

Pragmatic Free Trail Meta is an open data platform that allows research into pragmatic trials. It collects and distributes cleaned trial data, ratings, and evaluations using PRECIS-2. This allows for a variety of meta-epidemiological analyses that evaluate the effects of treatment across trials of various levels of pragmatism.

Background

Pragmatic trials are increasingly recognized as providing real-world evidence for clinical decision making. However, the usage of the term "pragmatic" is inconsistent and its definition and evaluation requires further clarification. The purpose of pragmatic trials is to inform policy and clinical practice decisions, not to confirm the validity of a clinical or physiological hypothesis. A pragmatic trial should try to be as close as is possible to real-world clinical practices, including recruitment of participants, setting, designing, delivery and implementation of interventions, determining and analysis outcomes, and primary analyses. This is a major difference between explanatory trials as defined by Schwartz & Lellouch1 that are designed to confirm the hypothesis in a more thorough manner.

Truely pragmatic trials should not blind participants or the clinicians. This can result in a bias in the estimates of the effect of treatment. Pragmatic trials should also seek to attract patients from a wide range of health care settings, to ensure that the results can be compared to the real world.

Furthermore, trials that are pragmatic must be focused on outcomes that matter to patients, such as quality of life and functional recovery. This is particularly relevant in trials that involve surgical procedures that are invasive or have potential for dangerous adverse events. The CRASH trial29, for example was focused on functional outcomes to compare a 2-page case-report with an electronic system for monitoring of patients admitted to hospitals with chronic heart failure. In addition, the catheter trial28 used urinary tract infections caused by catheters as the primary outcome.

In addition to these characteristics pragmatic trials should reduce the trial procedures and 프라그마틱 슬롯 사이트 프라그마틱 정품확인방법 - isocialfans.com, data collection requirements in order to reduce costs. Additionally, pragmatic trials should aim to make their findings as applicable to current clinical practice as is possible. This can be accomplished by ensuring that their analysis is based on an intention-to treat approach (as described in CONSORT extensions).

Many RCTs that do not meet the criteria for pragmatism however, they have characteristics that are contrary to pragmatism have been published in journals of varying types and incorrectly labeled pragmatic. This could lead to false claims of pragmatism, and the use of the term should be standardized. The development of a PRECIS-2 tool that provides an objective and standardized evaluation of pragmatic aspects is a first step.

Methods

In a pragmatic study the goal is to inform policy or clinical decisions by showing how an intervention could be incorporated into real-world routine care. This is different from explanatory trials that test hypotheses regarding the causal-effect relationship in idealized conditions. Therefore, pragmatic trials might have lower internal validity than explanatory trials and might be more susceptible to bias in their design, conduct and analysis. Despite these limitations, pragmatic trials may contribute valuable information to decisions in the context of healthcare.

The PRECIS-2 tool evaluates an RCT on 9 domains, with scores ranging from 1 to 5 (very pragmatic). In this study, the recruit-ment organization, flexibility in delivery and follow-up domains scored high scores, however the primary outcome and the method of missing data were below the limit of practicality. This suggests that it is possible to design a trial that has good pragmatic features without damaging the quality of its results.

However, it is difficult to judge how practical a particular trial is since pragmaticity is not a definite attribute; some aspects of a trial can be more pragmatic than others. A trial's pragmatism can be affected by changes to the protocol or logistics during the trial. Koppenaal and colleagues found that 36% of 89 pragmatic studies were placebo-controlled, or conducted prior to the licensing. Most were also single-center. They aren't in line with the standard practice, and can only be called pragmatic if the sponsors agree that such trials aren't blinded.

Furthermore, a common feature of pragmatic trials is that researchers attempt to make their findings more meaningful by analysing subgroups of the trial. However, this can lead to unbalanced results and lower statistical power, which increases the risk of either not detecting or incorrectly detecting differences in the primary outcome. This was the case in the meta-analysis of pragmatic trials as secondary outcomes were not corrected for covariates that differed at the baseline.

In addition, pragmatic trials can also have challenges with respect to the gathering and interpretation of safety data. It is because adverse events tend to be self-reported and are susceptible to errors, delays or coding errors. Therefore, it is crucial to enhance the quality of outcomes ascertainment in these trials, in particular by using national registries instead of relying on participants to report adverse events in the trial's database.

Results

Although the definition of pragmatism does not require that all clinical trials are 100% pragmatist There are advantages when incorporating pragmatic components into trials. These include:

By incorporating routine patients, the results of the trial can be translated more quickly into clinical practice. However, pragmatic trials can also have drawbacks. The right kind of heterogeneity, 프라그마틱 무료스핀 플레이 - click the up coming article - like could help a study generalise its findings to many different patients or settings. However, the wrong type can reduce the sensitivity of an assay and thus reduce a trial's power to detect small treatment effects.

Numerous studies have attempted to categorize pragmatic trials, using various definitions and 프라그마틱 슈가러쉬 scoring systems. Schwartz and Lellouch1 created a framework for distinguishing between research studies that prove a physiological or clinical hypothesis as well as pragmatic trials that aid in the selection of appropriate treatments in clinical practice. The framework was comprised of nine domains that were evaluated on a scale of 1-5 which indicated that 1 was more lucid while 5 was more pragmatic. The domains included recruitment, setting up, delivery of intervention, flex adherence and primary analysis.

The initial PRECIS tool3 included similar domains and an assessment scale ranging from 1 to 5. Koppenaal et al10 developed an adaptation of this assessment, known as the Pragmascope which was more user-friendly to use for systematic reviews. They discovered that pragmatic systematic reviews had higher average score in most domains, but lower scores in the primary analysis domain.

This difference in primary analysis domains could be explained by the way that most pragmatic trials analyse data. Certain explanatory trials however do not. The overall score for systematic reviews that were pragmatic was lower when the areas of organisation, flexible delivery and follow-up were merged.

It is important to remember that the term "pragmatic trial" does not necessarily mean a poor quality trial, and there is an increasing number of clinical trials (as defined by MEDLINE search, however this is not sensitive nor specific) which use the word 'pragmatic' in their abstracts or titles. These terms may signal a greater awareness of pragmatism within abstracts and titles, however it's unclear whether this is reflected in content.

Conclusions

As the value of real-world evidence grows popular, pragmatic trials have gained popularity in research. They are clinical trials randomized which compare real-world treatment options rather than experimental treatments under development. They have populations of patients that more closely mirror the ones who are treated in routine care, they use comparators which exist in routine practice (e.g., existing drugs) and depend on the self-reporting of participants about outcomes. This approach could help overcome the limitations of observational studies which include the biases that arise from relying on volunteers, and the limited accessibility and coding flexibility in national registry systems.

Other advantages of pragmatic trials are the possibility of using existing data sources, as well as a higher chance of detecting meaningful changes than traditional trials. However, these trials could be prone to limitations that compromise their reliability and generalizability. For instance, participation rates in some trials may be lower than anticipated due to the healthy-volunteer influence and financial incentives or competition for participants from other research studies (e.g., industry trials). A lot of pragmatic trials are restricted by the need to enroll participants in a timely manner. Practical trials aren't always equipped with controls to ensure that the observed differences aren't caused by biases during the trial.

The authors of the Pragmatic Free Trial Meta identified 48 RCTs that self-labeled themselves as pragmatic and that were published up to 2022. The PRECIS-2 tool was used to evaluate the pragmatism of these trials. It covers areas like eligibility criteria, recruitment flexibility and adherence to intervention and follow-up. They discovered that 14 of the trials scored pragmatic or highly practical (i.e. scores of 5 or higher) in one or more of these domains and that the majority were single-center.

Trials with high pragmatism scores are likely to have more lenient criteria for eligibility than conventional RCTs. They also have populations from many different hospitals. The authors suggest that these characteristics could make pragmatic trials more effective and relevant to daily practice, but they do not necessarily guarantee that a pragmatic trial is free of bias. Moreover, the pragmatism of the trial is not a fixed attribute; a pragmatic trial that does not have all the characteristics of an explanatory trial may yield valuable and reliable results.